Investors

Public Company Filings

December 25, 2025

Business Update and Financing Overview December 2025

May 8, 2025

Prospectus for admission to trading on Nasdaq Stockholm and offering to the public in Sweden

March 26, 2025

Fréttatilkynning FY 2024

June 28, 2024

Alvotech EU Taxonomy Disclosure for 2023

June 28, 2024

Equality Report for 2023

July 12, 2023

Previously disclosed partnership agreements between Alvotech and STADA and Advanz Pharma

February 5, 2023

Convertible bonds (ALVCVB251220) Description for Listing

December 5, 2022

Alvotech Prospectus Nasdaq Iceland Main Market Listing

December 5, 2022

Alvotech íslensk samantekt skráningarlýsingar

December 1, 2022

Announcement of Restricted Share Unit Agreements

November 17, 2022

Financing arrangements announced November 16 2022

June 22, 2022

Supplement to the Company Description dated June 21 2022 with filed Form 20-F

June 20, 2022

Alvotech Company Description for Listing of Shares on Nasdaq First North Iceland June 2022

March 31, 2022

Equality Report 2021